genia tagger: 471('gt', 10)
('0\\.74\\\xe2\\\x80\\\x931\\.58', 2)
('alleles', 4)
('gg', 64)
('0\\.80\\\xe2\\\x80\\\x932\\.10', 2)
('1\\.30', 8)
('cases', 27)
('0\\.79\\\xe2\\\x80\\\x931\\.22', 6)
('tt', 60)
('344', 2)
('0', 1837)
('346', 2)
('347', 6)
('343', 4)
('348', 2)
('349', 2)
('6\\.9', 2)
('0\\.85\\\xe2\\\x80\\\x931\\.55', 2)
('risk', 34)
('718', 4)
('regional', 2)
('711', 6)
('p', 385)
('cyp24b1', 4)
('291', 2)
('593', 4)
('22\\.7', 2)
('190', 6)
('193', 4)
('192', 4)
('270', 2)
('272', 2)
('278', 2)
('1\\.46', 8)
('0\\.80\\\xe2\\\x80\\\x931\\.33', 2)
('rs6823', 2)
('528', 2)
('302', 2)
('genes', 10)
('108', 6)
('3\\.4', 4)
('rs2071358', 2)
('103', 8)
('0\\.56\\\xe2\\\x80\\\x931\\.87', 2)
('101', 2)
('106', 4)
('107', 12)
('39', 50)
('38', 57)
('33', 54)
('32', 63)
('31', 51)
('30', 55)
('37', 68)
('36', 63)
('35', 66)
('34', 58)
('rdd', 2)
('0\\.17\\\xe2\\\x80\\\x931\\.39', 2)
('437', 2)
('434', 2)
('gene', 22)
('432', 4)
('rs10735810', 5)
('0\\.68', 14)
('335', 2)
('0\\.64', 6)
('1\\.74', 4)
('0\\.63', 6)
('0\\.62', 12)
('0\\.61\\\xe2\\\x80\\\x933\\.70', 2)
('apa', 3)
('apai', 1)
('0\\.79\\\xe2\\\x80\\\x931\\.60', 2)
('0\\.38\\\xe2\\\x80\\\x934\\.11', 2)
('0\\.19', 6)
('0\\.57', 12)
('6', 765)
('rs2238135', 5)
('99', 16)
('91', 34)
('90', 22)
('93', 28)
('92', 22)
('95', 43)
('97', 17)
('96', 32)
('none', 4)
('cyp27b1', 11)
('558', 2)
('loci', 3)
('2\\.27', 4)
('232', 7)
('233', 2)
('1\\.95', 3)
('1', 1834)
('147', 4)
('6\\.3', 6)
('143', 4)
('140', 2)
('141', 2)
('0\\.61\\\xe2\\\x80\\\x930\\.96', 4)
('prostate', 30)
('a', 1265)
('0\\.46\\\xe2\\\x80\\\x931\\.33', 2)
('1\\.70', 2)
('132', 2)
('131', 2)
('130', 6)
('1\\.28\\\xe2\\\x80\\\x932\\.26', 2)
('yp24a1', 12)
('135', 9)
('134', 2)
('494', 2)
('0\\.81\\\xe2\\\x80\\\x931\\.49', 2)
('24', 88)
('25', 82)
('26', 73)
('27', 73)
('20', 66)
('21', 53)
('22', 67)
('23', 55)
('28', 50)
('29', 56)
('406', 4)
('405', 2)
('404', 4)
('400', 2)
('pca', 14)
('1\\.25', 10)
('1\\.26', 10)
('1\\.29', 12)
('0\\.77\\\xe2\\\x80\\\x931\\.46', 2)
('holick', 2)
('0\\.21', 6)
('0\\.78\\\xe2\\\x80\\\x931\\.29', 2)
('0\\.26', 8)
('371', 4)
('373', 2)
('0\\.78\\\xe2\\\x80\\\x931\\.20', 2)
('taqi', 3)
('rs2544038', 2)
('0\\.54\\\xe2\\\x80\\\x931\\.37', 2)
('rs13038432', 2)
('82', 51)
('181', 6)
('80', 34)
('81', 54)
('86', 18)
('87', 47)
('84', 22)
('0\\.62\\\xe2\\\x80\\\x932\\.02', 2)
('7', 807)
('caucasian', 12)
('580', 2)
('rs11168287', 2)
('245', 4)
('rs4809960', 4)
('242', 2)
('0\\.72\\\xe2\\\x80\\\x931\\.68', 2)
('249', 2)
('248', 2)
('0\\.57\\\xe2\\\x80\\\x931\\.35', 2)
('518', 2)
('37\\.7', 2)
('512', 2)
('0\\.87', 16)
('rs4073729', 2)
('0\\.81\\\xe2\\\x80\\\x931\\.48', 2)
('1\\.50', 2)
('451', 4)
('319', 4)
('457', 2)
('16\\.2', 2)
('0\\.55\\\xe2\\\x80\\\x931\\.04', 2)
('176', 2)
('175', 4)
('172', 2)
('171', 2)
('0\\.55\\\xe2\\\x80\\\x931\\.74', 2)
('rs2762939', 2)
('unknown', 6)
('182', 6)
('183', 4)
('180', 4)
('2', 1175)
('185', 4)
('trend', 6)
('189', 4)
('0\\.64\\\xe2\\\x80\\\x931\\.18', 2)
('0\\.78', 22)
('0\\.79', 16)
('et', 36)
('0\\.77', 22)
('0\\.75', 14)
('0\\.66\\\xe2\\\x80\\\x931\\.19', 2)
('0\\.70', 10)
('0\\.71', 6)
('0\\.32\\\xe2\\\x80\\\x931\\.28', 2)
('foki', 3)
('314', 4)
('188', 4)
('11', 78)
('10', 98)
('13', 71)
('b', 261)
('15', 67)
('14', 56)
('17', 61)
('16', 66)
('19', 72)
('18', 80)
('stp', 4)
('rs2239182', 2)
('and', 68)
('0\\.74\\\xe2\\\x80\\\x931\\.79', 2)
('1\\.18', 8)
('1\\.15', 18)
('bsmi', 3)
('1\\.11', 10)
('1\\.10', 8)
('1\\.12', 16)
('rs3787557', 2)
('hapmap', 2)
('consortium', 2)
('322', 2)
('323', 2)
('324', 2)
('325', 2)
('328', 6)
('201', 2)
('gleason', 6)
('202', 2)
('207', 4)
('209', 4)
('1\\.64', 6)
('77', 26)
('76', 50)
('75', 39)
('74', 36)
('73', 43)
('72', 28)
('71', 36)
('70', 32)
('0\\.72\\\xe2\\\x80\\\x931\\.27', 2)
('2\\.30', 2)
('79', 33)
('78', 45)
('ex4\\+9', 2)
('0\\.80\\\xe2\\\x80\\\x931\\.46', 2)
('deactivatingenzyme', 1)
('rs927650', 2)
('rs11168314', 2)
('213', 4)
('enzyme', 3)
('8', 744)
('local', 4)
('rs2107301', 5)
('258', 6)
('0\\.23\\\xe2\\\x80\\\x931\\.08', 2)
('12', 73)
('127', 4)
('69', 24)
('0\\.26\\\xe2\\\x80\\\x931\\.61', 2)
('2\\.1', 26)
('0\\.33\\\xe2\\\x80\\\x932\\.40', 2)
('7\\.0\\\xe2\\\x80\\\x9312\\.9', 2)
('415', 2)
('413', 2)
('418', 2)
('419', 6)
('136', 2)
('1\\.51', 2)
('0\\.86', 8)
('0\\.85', 28)
('0\\.84', 8)
('0\\.83', 14)
('0\\.82', 22)
('reference', 162)
('312', 7)
('0\\.89', 10)
('0\\.88', 10)
('polymorphic', 2)
('0\\.45\\\xe2\\\x80\\\x931\\.12', 2)
('nuclear', 1)
('3', 993)
('score', 6)
('stata', 4)
('369', 2)
('367', 2)
('rs2585428', 2)
('363', 2)
('91\\.2', 2)
('snps', 18)
('vitamin', 22)
('380', 2)
('383', 2)
('387', 2)
('c', 1092)
('109', 2)
('ci', 48)
('cancer', 33)
('cc', 80)
('cg', 20)
('153', 4)
('60', 38)
('61', 50)
('62', 36)
('63', 24)
('64', 28)
('65', 22)
('66', 26)
('67', 40)
('68', 46)
('24-hydroxylase', 4)
('rs2244719', 2)
('253', 6)
('254', 4)
('255', 8)
('1-alpha-hydroxlase', 2)
('0\\.58\\\xe2\\\x80\\\x931\\.07', 2)
('468', 2)
('636', 2)
('637', 2)
('461', 2)
('0\\.80\\\xe2\\\x80\\\x931\\.25', 2)
('168', 8)
('169', 2)
('166', 2)
('167', 2)
('161', 2)
('0\\.49\\\xe2\\\x80\\\x931\\.85', 2)
('287', 4)
('0\\.49', 12)
('0\\.48', 10)
('rs10875694', 2)
('1\\.16', 12)
('rs3782905', 2)
('0\\.84\\\xe2\\\x80\\\x931\\.45', 2)
('9', 628)
('rs2408876', 2)
('0\\.48\\\xe2\\\x80\\\x930\\.95', 4)
('0\\.77\\\xe2\\\x80\\\x931\\.24', 2)
('23\\.2', 2)
('1\\.08', 16)
('1\\.09', 8)
('1\\.06', 10)
('1\\.07', 14)
('rs6127118', 2)
('1\\.02', 4)
('1\\.03', 12)
('1\\.00', 174)
('i', 990)
('0\\.85\\\xe2\\\x80\\\x931\\.84', 2)
('no', 92)
('356', 4)
('354', 2)
('350', 2)
('rs912505', 4)
('11\\.8', 2)
('359', 2)
('358', 9)
('217', 4)
('212', 6)
('-hydroxylase', 7)
('21\\.8', 2)
('218', 6)
('0\\.54\\\xe2\\\x80\\\x931\\.13', 2)
('distant', 2)
('human', 2)
('rs4646537', 2)
('yes', 2)
('cyp27a1', 4)
('\\?', 101)
('0\\.65', 6)
('\\%', 36)
('4', 960)
('5', 873)
('\\(', 1769)
('\\)', 1769)
('676', 2)
('psa', 6)
('263', 2)
('262', 2)
('261', 2)
('266', 2)
('variants', 2)
('rs7299460', 2)
('58', 59)
('vdr', 22)
('59', 30)
('d', 554)
('55', 40)
('54', 63)
('57', 44)
('56', 24)
('51', 50)
('50', 48)
('53', 36)
('52', 40)
('rs2181874', 2)
('rs739837', 2)
('genes\\.', 4)
('203', 2)
('114', 2)
('116', 12)
('rs7974708', 2)
('table', 14)
('rs2245153', 2)
('118', 4)
('rs11168275', 2)
('ct', 114)
('425', 2)
('0\\.91', 18)
('0\\.94', 10)
('0\\.95', 18)
('0\\.97', 8)
('0\\.98', 14)
('17\\.5', 2)
('303', 4)
('yp27b1', 12)
('rs6022999', 2)
('376', 2)
('or', 150)
('block', 76)
('receptor', 4)
('cyp24a1', 11)
('rs3782130', 2)
('223', 13)
('220', 4)
('\xc2\xa7', 6)
('cells', 1)
('26\\.3', 2)
('ivs7\\+204', 2)
('26\\.6', 2)
('aa', 44)
('ac', 38)
('ag', 98)
('159', 2)
('al', 122)
('0\\.68\\\xe2\\\x80\\\x931\\.22', 2)
('rs731236', 5)
('at', 208)
('83', 32)
('d-related', 1)
('48', 60)
('49', 64)
('46', 66)
('47', 63)
('44', 37)
('45', 48)
('42', 40)
('43', 48)
('40', 50)
('41', 49)
('24\\.5', 2)
('81\\.7', 2)
('24\\.1', 4)
('genome', 2)
('test', 12)
('85', 46)
('0\\.78\\\xe2\\\x80\\\x931\\.48', 2)
('\xe2\x80\xa0', 14)
('487', 2)
('485', 2)
('\xe2\x80\x93', 471)
('0\\.59\\\xe2\\\x80\\\x931\\.34', 2)
('470', 6)
('diagnosis', 4)
('475', 2)


spacy + metamap: 296('gleason scores', 2)
('selection', 8)
('supplement', 2)
('less', 5)
('duplicates', 2)
('percent', 4)
('random', 2)
('adjusted', 14)
('excretion product', 1)
('gg', 64)
('neoplastic process', 1)
('inconsistent', 1)
('statistical', 6)
('vitamin d', 22)
('unknown', 6)
('adjustment', 4)
('king county', 2)
('decade', 1)
('duplicated', 2)
('statistical methods', 2)
('tables', 2)
('inverse', 1)
('group', 8)
('tx', 2)
('eligible', 8)
('daily', 2)
('tt', 60)
('source', 1)
('enzyme', 3)
('program', 2)
('degrees', 2)
('board', 4)
('ag', 98)
('alleles', 4)
('allele', 11)
('regional', 2)
('local', 4)
('plasma', 2)
('associations', 6)
('sound', 2)
('digit', 2)
('hormone', 1)
('homozygous', 4)
('risk', 34)
('apoptosis', 1)
('national human genome research institute', 2)
('\\+5', 4)
('\\+2', 12)
('single nucleotide polymorphisms', 1)
('period', 3)
('test', 12)
('ultraviolet', 1)
('effects', 2)
('cg', 20)
('african american', 12)
('years', 8)
('exact', 2)
('association', 12)
('matched', 3)
('case-control study', 6)
('vdr', 22)
('moderate', 2)
('only', 5)
('55', 40)
('january', 2)
('future', 2)
('detectable', 2)
('genotypes', 10)
('race', 6)
('form', 2)
('common', 7)
('logistic regression', 2)
('69', 24)
('methods', 5)
('findings', 8)
('trend', 6)
('testing', 4)
('estimates', 6)
('homozygote', 4)
('related', 1)
('global', 2)
('individual', 5)
('college', 2)
('result', 6)
('vitamin d intake', 2)
('measurement', 1)
('coverage', 2)
('multiple', 8)
('little', 2)
('polymorphic', 2)
('histologically', 2)
('subject', 6)
('instance', 2)
('dial', 2)
('total', 6)
('odds ratio', 6)
('power', 4)
('total vitamin d', 4)
('nuclear', 1)
('review', 4)
('selected', 4)
('forty', 1)
('case', 37)
('version', 2)
('tests', 6)
('genotype', 14)
('genotypic', 2)
('stp', 4)
('previous', 8)
('caucasian', 12)
('minimal', 2)
('available', 2)
('variability', 2)
('earlier', 5)
('1\\+', 8)
('national cancer institute', 2)
('snps', 18)
('vitamin d metabolism', 1)
('genotyping', 8)
('genes', 10)
('agreement', 2)
('effect', 10)
('lack', 2)
('epidemiology', 2)
('incident', 1)
('p-value', 2)
('diet', 2)
('haplotypes', 3)
('active', 1)
('strong', 3)
('properties', 1)
('stage', 6)
('institutional review board', 2)
('package', 2)
('one', 15)
('carcinogenesis', 1)
('study', 22)
('23', 55)
('tumor', 7)
('prior', 4)
('permutation', 2)
('gene', 22)
('studies', 5)
('block', 76)
('blind', 2)
('resequencing', 2)
('cellular proliferation', 1)
('relevant', 1)
('snp', 32)
('cancer', 33)
('cc', 80)
('corp\\.', 2)
('variables', 2)
('rdd', 2)
('stratification', 2)
('primary', 1)
('three', 1)
('variable', 4)
('prostate cancer', 29)
('65', 22)
('family history', 2)
('68', 46)
('table', 14)
('apa', 3)
('ct', 114)
('age groups', 2)
('given', 2)
('cyp24a1', 11)
('relative risk', 4)
('apai', 1)
('failed', 2)
('introduction', 1)
('leukocyte', 4)
('ci', 48)
('two', 3)
('hydroxylase', 7)
('genetic', 4)
('clinical', 1)
('low', 5)
('characteristics', 2)
('percentage', 2)
('african americans', 6)
('minor', 2)
('uv light exposure', 2)
('function', 1)
('0\\%', 2)
('modification', 2)
('relationship', 2)
('comparison', 6)
('numbers', 2)
('risk estimate', 6)
('odds ratios', 4)
('significant', 12)
('part', 2)
('link', 1)
('regression', 4)
('number', 6)
('cases', 27)
('goal', 2)
('97', 17)
('population', 12)
('antiangiogenic', 1)
('prostate cancer risk', 6)
('intake', 6)
('caucasians', 4)
('washington', 2)
('wildtype', 2)
('cells', 1)
('3\\+', 6)
('measures', 3)
('population study', 2)
('frequency', 4)
('stage tumor', 2)
('freedom', 2)
('polymorphisms', 6)
('distribution', 4)
('overall', 3)
('unconditional', 2)
('history', 4)
('control', 31)
('aa', 44)
('tagsnp', 14)
('gene variant', 2)
('seer', 2)
('metropolitan', 2)
('december', 2)
('year', 10)
('ages', 2)
('telephone', 2)
('al', 122)
('evidence', 8)
('tag', 23)
('statistical analysis', 2)
('follow-up', 1)
('aggressiveness', 3)
('station', 2)
('null', 2)
('serum', 1)
('ethnicity', 2)
('dominant', 2)
('calcium intake', 2)
('functions', 1)
('genetic variation', 2)
('end', 8)
('apoptotic', 1)
('carriers', 7)
('hapmap', 2)
('discussion', 2)
('allele frequency', 2)
('vitamin d receptor', 4)
('consortium', 2)
('surveillance', 2)
('cyp27a1', 4)
('majority', 2)
('internal', 2)
('interview', 4)
('additional', 2)
('pathway', 4)
('ac', 38)
('higher', 3)
('status', 1)
('age group', 4)
('psa', 6)
('altered', 5)
('prostate cancers', 2)
('models', 2)
('comprehensive', 3)
('incidence', 1)
('variant', 6)
('confirmed', 2)
('variation', 4)
('gt', 10)
('most', 2)
('levels', 2)
('eight', 1)
('men', 13)
('date', 2)
('frequently', 3)
('score', 6)
('data', 8)
('model', 8)
('reference', 162)
('exposure', 4)
('lower', 2)
('fred hutchinson cancer research center', 2)
('slightly', 2)
('age', 27)
('linear', 2)
('disease progression', 2)
('disease', 4)
('analysis', 7)
('80\\%', 2)
('materials', 1)
('diagnosis', 4)
('angiogenesis', 1)
('odd ratio', 2)


total: 718('gt', 10)
('0\\.74\\\xe2\\\x80\\\x931\\.58', 2)
('duplicates', 2)
('alleles', 4)
('global', 2)
('gg', 64)
('0\\.80\\\xe2\\\x80\\\x932\\.10', 2)
('supplement', 2)
('1\\.30', 8)
('cases', 27)
('duplicated', 2)
('0\\.79\\\xe2\\\x80\\\x931\\.22', 6)
('inverse', 1)
('number', 6)
('tx', 2)
('eligible', 8)
('tt', 60)
('344', 2)
('0', 1837)
('346', 2)
('347', 6)
('343', 4)
('348', 2)
('349', 2)
('6\\.9', 2)
('digit', 2)
('0\\.85\\\xe2\\\x80\\\x931\\.55', 2)
('risk', 34)
('718', 4)
('apoptosis', 1)
('regional', 2)
('\\+2', 12)
('intake', 6)
('711', 6)
('ultraviolet', 1)
('exact', 2)
('moderate', 2)
('p', 385)
('race', 6)
('cyp24b1', 4)
('291', 2)
('593', 4)
('findings', 8)
('22\\.7', 2)
('estimates', 6)
('190', 6)
('193', 4)
('192', 4)
('270', 2)
('272', 2)
('278', 2)
('1\\.46', 8)
('linear', 2)
('0\\.80\\\xe2\\\x80\\\x931\\.33', 2)
('dial', 2)
('adjustment', 4)
('disease', 4)
('version', 2)
('rs6823', 2)
('vitamin d metabolism', 1)
('528', 2)
('302', 2)
('national cancer institute', 2)
('genotyping', 8)
('genes', 10)
('lack', 2)
('108', 6)
('3\\.4', 4)
('rs2071358', 2)
('histologically', 2)
('active', 1)
('103', 8)
('0\\.56\\\xe2\\\x80\\\x931\\.87', 2)
('101', 2)
('106', 4)
('107', 12)
('institutional review board', 2)
('39', 50)
('38', 57)
('33', 54)
('32', 63)
('31', 51)
('30', 55)
('37', 68)
('36', 63)
('35', 66)
('34', 58)
('calcium intake', 2)
('rdd', 2)
('0\\.17\\\xe2\\\x80\\\x931\\.39', 2)
('data', 8)
('permutation', 2)
('437', 2)
('434', 2)
('gene', 22)
('432', 4)
('rs10735810', 5)
('gleason scores', 2)
('0\\.68', 14)
('335', 2)
('0\\.64', 6)
('1\\.74', 4)
('0\\.63', 6)
('0\\.62', 12)
('0\\.61\\\xe2\\\x80\\\x933\\.70', 2)
('apa', 3)
('odd ratio', 2)
('relative risk', 4)
('apai', 1)
('0\\.79\\\xe2\\\x80\\\x931\\.60', 2)
('0\\.38\\\xe2\\\x80\\\x934\\.11', 2)
('0\\.19', 6)
('0\\.57', 12)
('6', 765)
('rs2238135', 5)
('stage', 6)
('minor', 2)
('0\\%', 2)
('odds ratios', 4)
('telephone', 2)
('99', 16)
('91', 34)
('90', 22)
('93', 28)
('92', 22)
('95', 43)
('97', 17)
('96', 32)
('antiangiogenic', 1)
('none', 4)
('package', 2)
('cyp27b1', 11)
('freedom', 2)
('unconditional', 2)
('history', 4)
('control', 31)
('558', 2)
('december', 2)
('loci', 3)
('\\+5', 4)
('tag', 23)
('2\\.27', 4)
('allele frequency', 2)
('station', 2)
('serum', 1)
('232', 7)
('233', 2)
('1\\.95', 3)
('end', 8)
('goal', 2)
('carriers', 7)
('discussion', 2)
('80\\%', 2)
('1', 1834)
('interview', 4)
('pathway', 4)
('147', 4)
('6\\.3', 6)
('143', 4)
('140', 2)
('141', 2)
('earlier', 5)
('variant', 6)
('studies', 5)
('snp', 32)
('0\\.61\\\xe2\\\x80\\\x930\\.96', 4)
('date', 2)
('prostate', 30)
('a', 1265)
('fred hutchinson cancer research center', 2)
('disease progression', 2)
('0\\.46\\\xe2\\\x80\\\x931\\.33', 2)
('resequencing', 2)
('numbers', 2)
('excretion product', 1)
('1\\.70', 2)
('132', 2)
('131', 2)
('130', 6)
('1\\.28\\\xe2\\\x80\\\x932\\.26', 2)
('yp24a1', 12)
('135', 9)
('134', 2)
('494', 2)
('0\\.81\\\xe2\\\x80\\\x931\\.49', 2)
('24', 88)
('25', 82)
('26', 73)
('27', 73)
('20', 66)
('21', 53)
('22', 67)
('23', 55)
('28', 50)
('29', 56)
('406', 4)
('405', 2)
('404', 4)
('degrees', 2)
('400', 2)
('pca', 14)
('1\\.25', 10)
('1\\.26', 10)
('washington', 2)
('1\\.29', 12)
('primary', 1)
('modification', 2)
('0\\.77\\\xe2\\\x80\\\x931\\.46', 2)
('effects', 2)
('one', 15)
('association', 12)
('matched', 3)
('january', 2)
('holick', 2)
('0\\.21', 6)
('0\\.78\\\xe2\\\x80\\\x931\\.29', 2)
('testing', 4)
('logistic regression', 2)
('0\\.26', 8)
('371', 4)
('373', 2)
('0\\.78\\\xe2\\\x80\\\x931\\.20', 2)
('taqi', 3)
('rs2544038', 2)
('related', 1)
('0\\.54\\\xe2\\\x80\\\x931\\.37', 2)
('rs13038432', 2)
('measurement', 1)
('82', 51)
('181', 6)
('80', 34)
('81', 54)
('86', 18)
('87', 47)
('84', 22)
('0\\.62\\\xe2\\\x80\\\x932\\.02', 2)
('prostate cancers', 2)
('forty', 1)
('p-value', 2)
('7', 807)
('caucasian', 12)
('1\\+', 8)
('580', 2)
('rs11168287', 2)
('little', 2)
('245', 4)
('rs4809960', 4)
('242', 2)
('0\\.72\\\xe2\\\x80\\\x931\\.68', 2)
('249', 2)
('248', 2)
('0\\.57\\\xe2\\\x80\\\x931\\.35', 2)
('518', 2)
('levels', 2)
('37\\.7', 2)
('512', 2)
('blind', 2)
('0\\.87', 16)
('cellular proliferation', 1)
('rs4073729', 2)
('0\\.81\\\xe2\\\x80\\\x931\\.48', 2)
('1\\.50', 2)
('451', 4)
('variables', 2)
('319', 4)
('457', 2)
('16\\.2', 2)
('0\\.55\\\xe2\\\x80\\\x931\\.04', 2)
('family history', 2)
('frequently', 3)
('176', 2)
('175', 4)
('172', 2)
('171', 2)
('0\\.55\\\xe2\\\x80\\\x931\\.74', 2)
('given', 2)
('genotype', 14)
('rs2762939', 2)
('unknown', 6)
('adjusted', 14)
('odds ratio', 6)
('hydroxylase', 7)
('182', 6)
('183', 4)
('180', 4)
('2', 1175)
('185', 4)
('trend', 6)
('189', 4)
('african americans', 6)
('0\\.64\\\xe2\\\x80\\\x931\\.18', 2)
('0\\.78', 22)
('0\\.79', 16)
('et', 36)
('0\\.77', 22)
('0\\.75', 14)
('0\\.66\\\xe2\\\x80\\\x931\\.19', 2)
('0\\.70', 10)
('0\\.71', 6)
('0\\.32\\\xe2\\\x80\\\x931\\.28', 2)
('part', 2)
('foki', 3)
('314', 4)
('188', 4)
('population', 12)
('11', 78)
('10', 98)
('13', 71)
('b', 261)
('15', 67)
('14', 56)
('17', 61)
('16', 66)
('19', 72)
('18', 80)
('future', 2)
('stp', 4)
('rs2239182', 2)
('and', 68)
('0\\.74\\\xe2\\\x80\\\x931\\.79', 2)
('tagsnp', 14)
('seer', 2)
('ages', 2)
('1\\.18', 8)
('1\\.15', 18)
('bsmi', 3)
('1\\.11', 10)
('1\\.10', 8)
('1\\.12', 16)
('rs3787557', 2)
('apoptotic', 1)
('hapmap', 2)
('corp\\.', 2)
('consortium', 2)
('322', 2)
('323', 2)
('materials', 1)
('324', 2)
('325', 2)
('328', 6)
('201', 2)
('age group', 4)
('gleason', 6)
('202', 2)
('altered', 5)
('207', 4)
('209', 4)
('1\\.64', 6)
('measures', 3)
('77', 26)
('76', 50)
('75', 39)
('74', 36)
('73', 43)
('72', 28)
('71', 36)
('70', 32)
('0\\.72\\\xe2\\\x80\\\x931\\.27', 2)
('2\\.30', 2)
('79', 33)
('78', 45)
('hormone', 1)
('ex4\\+9', 2)
('0\\.80\\\xe2\\\x80\\\x931\\.46', 2)
('selection', 8)
('deactivatingenzyme', 1)
('random', 2)
('rs927650', 2)
('inconsistent', 1)
('rs11168314', 2)
('decade', 1)
('213', 4)
('daily', 2)
('failed', 2)
('enzyme', 3)
('uv light exposure', 2)
('8', 744)
('local', 4)
('dominant', 2)
('prostate cancer risk', 6)
('rs2107301', 5)
('258', 6)
('overall', 3)
('single nucleotide polymorphisms', 1)
('0\\.23\\\xe2\\\x80\\\x931\\.08', 2)
('12', 73)
('127', 4)
('african american', 12)
('years', 8)
('69', 24)
('0\\.26\\\xe2\\\x80\\\x931\\.61', 2)
('2\\.1', 26)
('0\\.33\\\xe2\\\x80\\\x932\\.40', 2)
('7\\.0\\\xe2\\\x80\\\x9312\\.9', 2)
('415', 2)
('neoplastic process', 1)
('common', 7)
('413', 2)
('418', 2)
('419', 6)
('136', 2)
('1\\.51', 2)
('0\\.86', 8)
('0\\.85', 28)
('0\\.84', 8)
('0\\.83', 14)
('0\\.82', 22)
('reference', 162)
('312', 7)
('vitamin d', 22)
('0\\.89', 10)
('0\\.88', 10)
('individual', 5)
('college', 2)
('result', 6)
('vitamin d intake', 2)
('polymorphic', 2)
('subject', 6)
('instance', 2)
('0\\.45\\\xe2\\\x80\\\x931\\.12', 2)
('nuclear', 1)
('review', 4)
('case', 37)
('3', 993)
('score', 6)
('stata', 4)
('369', 2)
('367', 2)
('rs2585428', 2)
('363', 2)
('91\\.2', 2)
('available', 2)
('variability', 2)
('men', 13)
('tables', 2)
('snps', 18)
('vitamin', 22)
('380', 2)
('incident', 1)
('383', 2)
('387', 2)
('group', 8)
('leukocyte', 4)
('c', 1092)
('3\\+', 6)
('109', 2)
('ci', 48)
('relevant', 1)
('cancer', 33)
('cc', 80)
('cg', 20)
('153', 4)
('60', 38)
('61', 50)
('62', 36)
('63', 24)
('64', 28)
('65', 22)
('66', 26)
('67', 40)
('68', 46)
('24-hydroxylase', 4)
('rs2244719', 2)
('253', 6)
('254', 4)
('255', 8)
('age groups', 2)
('strong', 3)
('1-alpha-hydroxlase', 2)
('source', 1)
('three', 1)
('genetic', 4)
('board', 4)
('0\\.58\\\xe2\\\x80\\\x931\\.07', 2)
('468', 2)
('636', 2)
('637', 2)
('461', 2)
('0\\.80\\\xe2\\\x80\\\x931\\.25', 2)
('168', 8)
('169', 2)
('allele', 11)
('166', 2)
('167', 2)
('161', 2)
('sound', 2)
('caucasians', 4)
('0\\.49\\\xe2\\\x80\\\x931\\.85', 2)
('287', 4)
('haplotypes', 3)
('study', 22)
('homozygote', 4)
('program', 2)
('0\\.49', 12)
('0\\.48', 10)
('metropolitan', 2)
('characteristics', 2)
('rs10875694', 2)
('statistical analysis', 2)
('aggressiveness', 3)
('regression', 4)
('ethnicity', 2)
('confirmed', 2)
('1\\.16', 12)
('rs3782905', 2)
('prior', 4)
('0\\.84\\\xe2\\\x80\\\x931\\.45', 2)
('vitamin d receptor', 4)
('surveillance', 2)
('9', 628)
('national human genome research institute', 2)
('higher', 3)
('status', 1)
('rs2408876', 2)
('0\\.48\\\xe2\\\x80\\\x930\\.95', 4)
('comprehensive', 3)
('0\\.77\\\xe2\\\x80\\\x931\\.24', 2)
('null', 2)
('effect', 10)
('23\\.2', 2)
('genetic variation', 2)
('1\\.08', 16)
('1\\.09', 8)
('1\\.06', 10)
('1\\.07', 14)
('rs6127118', 2)
('1\\.02', 4)
('1\\.03', 12)
('1\\.00', 174)
('lower', 2)
('i', 990)
('0\\.85\\\xe2\\\x80\\\x931\\.84', 2)
('no', 92)
('analysis', 7)
('356', 4)
('354', 2)
('350', 2)
('rs912505', 4)
('model', 8)
('11\\.8', 2)
('359', 2)
('358', 9)
('217', 4)
('212', 6)
('-hydroxylase', 7)
('less', 5)
('percent', 4)
('21\\.8', 2)
('218', 6)
('0\\.54\\\xe2\\\x80\\\x931\\.13', 2)
('distant', 2)
('human', 2)
('rs4646537', 2)
('yes', 2)
('previous', 8)
('statistical methods', 2)
('cyp27a1', 4)
('majority', 2)
('\\?', 101)
('0\\.65', 6)
('\\%', 36)
('4', 960)
('5', 873)
('plasma', 2)
('\\(', 1769)
('\\)', 1769)
('associations', 6)
('tests', 6)
('homozygous', 4)
('676', 2)
('psa', 6)
('period', 3)
('263', 2)
('262', 2)
('261', 2)
('266', 2)
('variants', 2)
('rs7299460', 2)
('statistical', 6)
('58', 59)
('case-control study', 6)
('vdr', 22)
('59', 30)
('d', 554)
('55', 40)
('54', 63)
('57', 44)
('56', 24)
('51', 50)
('50', 48)
('53', 36)
('52', 40)
('rs2181874', 2)
('rs739837', 2)
('genes\\.', 4)
('203', 2)
('114', 2)
('116', 12)
('rs7974708', 2)
('table', 14)
('multiple', 8)
('rs2245153', 2)
('118', 4)
('total', 6)
('rs11168275', 2)
('genotypic', 2)
('ct', 114)
('425', 2)
('genotypes', 10)
('minimal', 2)
('0\\.91', 18)
('incidence', 1)
('0\\.94', 10)
('0\\.95', 18)
('power', 4)
('0\\.97', 8)
('0\\.98', 14)
('17\\.5', 2)
('303', 4)
('agreement', 2)
('epidemiology', 2)
('relationship', 2)
('diet', 2)
('total vitamin d', 4)
('properties', 1)
('yp27b1', 12)
('comparison', 6)
('most', 2)
('carcinogenesis', 1)
('tumor', 7)
('rs6022999', 2)
('eight', 1)
('376', 2)
('slightly', 2)
('or', 150)
('block', 76)
('significant', 12)
('stratification', 2)
('two', 3)
('variable', 4)
('receptor', 4)
('selected', 4)
('detectable', 2)
('methods', 5)
('cyp24a1', 11)
('additional', 2)
('clinical', 1)
('low', 5)
('wildtype', 2)
('function', 1)
('only', 5)
('form', 2)
('introduction', 1)
('link', 1)
('rs3782130', 2)
('223', 13)
('220', 4)
('\xc2\xa7', 6)
('cells', 1)
('population study', 2)
('frequency', 4)
('stage tumor', 2)
('26\\.3', 2)
('polymorphisms', 6)
('distribution', 4)
('ivs7\\+204', 2)
('26\\.6', 2)
('aa', 44)
('ac', 38)
('prostate cancer', 29)
('gene variant', 2)
('ag', 98)
('159', 2)
('year', 10)
('al', 122)
('evidence', 8)
('0\\.68\\\xe2\\\x80\\\x931\\.22', 2)
('rs731236', 5)
('at', 208)
('follow-up', 1)
('83', 32)
('internal', 2)
('functions', 1)
('d-related', 1)
('48', 60)
('49', 64)
('46', 66)
('47', 63)
('44', 37)
('45', 48)
('42', 40)
('43', 48)
('40', 50)
('41', 49)
('24\\.5', 2)
('81\\.7', 2)
('24\\.1', 4)
('genome', 2)
('test', 12)
('85', 46)
('0\\.78\\\xe2\\\x80\\\x931\\.48', 2)
('models', 2)
('risk estimate', 6)
('variation', 4)
('\xe2\x80\xa0', 14)
('coverage', 2)
('487', 2)
('485', 2)
('exposure', 4)
('\xe2\x80\x93', 471)
('age', 27)
('percentage', 2)
('king county', 2)
('0\\.59\\\xe2\\\x80\\\x931\\.34', 2)
('470', 6)
('diagnosis', 4)
('475', 2)
('angiogenesis', 1)
